AstraZeneca Wins European Approval for Lung Cancer Drug

AstraZeneca said European regulators have approved a potential blockbuster lung cancer drug that the company hopes will form a key plank of its growth plans.

from WSJ.com: US Business http://ift.tt/1R1fPlI
via IFTTT